[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
AI Research
Oxford, Ellison Institute Launch AI Vaccine Research

Led by the Oxford Vaccine Group , the new initiative based in the University – CoI-AI (Correlates of Immunity-Artificial Intelligence) – will combine Oxford’s expertise in human challenge studies, immune science and vaccine development with EITs cutting edge Artificial Intelligence (AI) innovation technology to better understand how the body fights infection and how vaccines protect us.
The CoI-AI programme will study how the immune system responds to important germs that cause serious infections and contribute to antibiotic resistance – such as Streptococcus pneumoniae, Staphylococcus aureus, and E. coli, – amongst others, which cause widespread illness but have resisted traditional vaccine approaches. Researchers will use human challenge models (where volunteers are safely exposed to bacteria under controlled conditions) and apply modern immunology and AI tools to pinpoint the immune responses that predict protection.
Professor Sir Andrew Pollard , Director of the Oxford Vaccine Group , said: ‘This programme addresses one of the most urgent problems in infectious disease by helping us to understand immunity more deeply to develop innovative vaccines against deadly diseases that have so far evaded our attempts at prevention. By combining advanced immunology with artificial intelligence, and using human challenge models to study diseases, CoI-AI will provide the tools we need to tackle serious infections and reduce the growing threat of antibiotic resistance. This is a new frontier in vaccine science.’
Professor Daniela Ferreira , Deputy Director of the Oxford Vaccine Group, said: ‘This programme will give us completely new tools to study how vaccines work at both a cellular and system-wide level, by studying infections in real time, in people, and using smart immunology tools and data to find the answers. This will open up whole new avenues to vaccine design as we improve our understanding of infection and immunity.’

Larry Ellison, Chairman of the Ellison Institute of Technology , said: ‘Researchers in the CoI-AI programme will use Artificial Intelligence models developed at EIT to identify and better understand the immune responses that predict protection. This vaccine development programme combines Oxford’s leadership in immunology and human challenge models with cutting-edge AI, laying the groundwork for a new era of vaccine discovery – one that is faster, smarter, and better able to respond to infectious disease outbreaks throughout the world.’
Professor Irene Tracey, Vice-Chancellor of the University of Oxford, said: ‘This is a major step forward in our strategic alliance with the Ellison Institute. Together, we’re combining Oxford’s strengths in vaccine science with EIT’s bold vision to tackle some of the toughest problems in global health. This is about drawing more talent and capacity to the Oxford ecosystem to turn scientific challenges into real solutions for the world.’
In December 2024 the University of Oxford and EIT announced a long-term strategic alliance to develop the solutions and future leaders needed to tackle some of the greatest and most enduring challenges facing humanity.
EIT combines cutting-edge research and commercial capability, to drive scientific breakthroughs and create sustainable, ethical companies, bringing together cross-cutting capabilities and talent spanning generative biology, clinical medicine, plant science, sustainable energy, public policy, and more.
These efforts are underpinned by substantial computing capability enabled by Oracle, a world-class Artificial Intelligence team, and a Scholars programme to develop future generations of the world’s finest scientists.
The Oxford Vaccine Group is a vaccine research group within the Department of Paediatrics at the University of Oxford’s Medical Sciences Division .
AI Research
Redefining the Future of Intelligent Productivity

iMini — The Super AI Agent redefining intelligence with seamless, reliable, one-stop experience.
With the rapid rise of global attention to AI agents, a breakthrough product has emerged: iMini, a super AI agent of world-class large-scale models. iMini is more than just a tool—it is a multi-role intelligent partner that is transforming the way professionals, students, and creators interact with artificial intelligence.
In today’s era of rapid advancements in artificial intelligence, iMini is emerging as a landmark representative of the new generation of super agents.While many similar products remain at the stage of simple assistance, iMini has already taken the lead in stepping into the era of “autonomous intelligence,” achieving a true end-to-end closed loop — from receiving tasks and gathering information to analysis, decision-making, and final delivery. Its arrival is reshaping the way humans collaborate with AI, earning recognition from the industry as both a disruptor and a pioneer in the intelligent agent field.
Also Read: AiThority Interview with Dr. Petar Tsankov, CEO and Co-Founder at LatticeFlow AI
One-stop Intelligent Experience: Integrated Knowledge and Reasoning Engines
Unlike platforms limited to a single function, iMini brings together multiple cutting-edge intelligent engines, combining powerful reasoning, data processing, and creative generation capabilities into one system. Users can obtain answers from different perspectives, cross-check insights, and uncover deeper connections while minimizing the risk of bias or misinformation. This holistic design makes iMini not only versatile but also exceptionally dependable in real-world applications, whether for research, business decision-making, or creative work.
Intelligent PPT and Report Creation
In today’s information-saturated world, producing high-quality, original, and professional PPTs or reports has become a challenge for both individuals and organizations. Traditional approaches often rely on template-based assembly, which lacks originality and logical depth. iMini breaks this limitation. It can automatically generate unique, tailor-made presentations based on simple user instructions while retrieving and analyzing relevant materials to form structured, coherent content. Unlike conventional “template-based” PPTs, iMini’s outputs are built on a complete understanding of the topic, ensuring that each report or presentation combines aesthetic design with professional rigor. Whether it’s a corporate strategy review, academic lecture, or investment proposal, iMini delivers truly original results that help users stand out in critical scenarios.
Use Cases:
·Business roadshows and fundraising presentations
·Company meetings and project reports
·Academic presentations and lectures
·Brand proposals and marketing plans
Full-Process Autonomous Workflow: From Instructions to Deliverables
iMini’s uniqueness lies not only in the quality and originality of its outputs but also in its near-human approach to completing tasks. When given a complex assignment, such as “create a business report on the trends in the renewable energy market,” iMini acts like a seasoned analyst: it autonomously searches for relevant information, performs logical analysis, structures the content, and delivers the final output. This end-to-end autonomous workflow can accomplish 80%-90% of human knowledge work. iMini is more than a tool—it functions as a smart assistant that reduces repetitive workload, freeing users to focus on strategic thinking and decision-making. This combination of efficiency and creativity is redefining the productivity of knowledge workers.
Use Cases:
·Market research and industry trend analysis
·Investment reports and strategic consulting
·Academic research and thesis preparation
·Internal project planning and review
Multi-Scenario Applications: Education, Research, and Creative Industries
iMini also excels in handling complex, multi-step tasks across diverse domains. In business planning, for instance, a few key instructions allow iMini to conduct market research, collect data, build logical frameworks, and generate visually compelling presentations or reports. Tasks that traditionally take days can now be completed in minutes, meeting professional standards. For executives, consultants, and investment managers, iMini is not merely a tool but a trusted collaborator—acting simultaneously as a researcher, strategist, and designer.
Beyond the corporate environment, iMini is opening new possibilities in education, research, and creative industries. Students and academics can use it to build research outlines, analyze data, and prepare presentations, freeing valuable time for critical thinking and innovation. Independent creators and freelancers can rely on iMini to produce high-quality proposals, design training modules, or create standout content for social media. Every output reflects precision and originality, ensuring users’ voices remain distinctive in an era of information overload.
Redefining Intelligent Productivity
With its ability to handle everything from writing and design to video production and data analysis, iMini stands at the forefront of the AI agent revolution. It is not just an assistant—it is a fully integrated intelligent partner, redefining how individuals and organizations achieve efficiency, creativity, and competitive advantage.
As artificial intelligence continues to evolve, the emergence of iMini signals a clear shift: the era of fragmented tools is giving way to the age of integrated Super AI Agents.
Also Read: Developing Autonomous Security Agents Using Computer Vision and Generative AI
AI Research
Oxford secures £118m for AI-driven vaccine research with Ellison Institute

The University of Oxford has launched a £118m AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials
A new initiative, led by Oxford Vaccine Group, named CoI-AI (Correlates of Immunity-Artificial Intelligence), will combine Oxford’s expertise in human challenge studies, immune science, and vaccine development with the Ellison Institute of Technology (EIT)’s Artificial Intelligence (AI) technology. The Ellison Institute will provide its advanced AI technology to the initiative, enhancing our understanding of infections and how vaccines protect us.
CoI-AI programme: Combining human challenge trials and artificial intelligence
The CoI-AI programme will focus on how the immune system responds to germs that cause serious infections and contribute to antibiotic resistance, such as Streptococcus pneumoniae, Staphylococcus aureus, and E. coli. Researchers will utilise human challenge models, where volunteers are safely exposed to bacteria under controlled conditions, and apply modern immunology and AI tools to pinpoint the immune responses that predict protection.
The CoI-AI programme, established in December 2024 through a strategic alliance between the University of Oxford and EIT, aims to develop solutions and create future leaders needed to tackle some of the most significant and challenging challenges facing humanity, thereby significantly impacting the global health landscape.
EIT is renowned for its groundbreaking research and commercial capabilities, driving scientific discoveries and fostering sustainable and ethical companies. The Ellison Institute combines cross-cutting capabilities and expertise in generative biology, clinical medicine, plant science, sustainable energy, public policy, and other related fields. The research is supported by substantial computing capability enabled by Oracle, a world-class Artificial Intelligence team, and a Scholars programme which aims to help the world’s finest up-and-coming scientists.
Tackling urgent problems in infectious diseases
Professor Sir Andrew Pollard, Director of the Oxford Vaccine Group, said: “This programme addresses one of the most urgent problems in infectious disease by helping us to understand immunity more deeply to develop innovative vaccines against deadly diseases that have so far evaded our attempts at prevention. By combining advanced immunology with artificial intelligence and utilising human challenge models to study diseases, CoI-AI will provide the tools necessary to tackle serious infections and mitigate the growing threat of antibiotic resistance. This is a new frontier in vaccine science.”
Professor Daniela Ferreira, Deputy Director of the Oxford Vaccine Group, said: “This programme will give us completely new tools to study how vaccines work at both a cellular and system-wide level, by studying infections in real time, in people, and using smart immunology tools and data to find the answers. This will open up whole new avenues to vaccine design as we improve our understanding of infection and immunity.”
Larry Ellison, Chairman of the Ellison Institute of Technology, said: “Researchers in the CoI-AI programme will use Artificial Intelligence models developed at EIT to identify and better understand the immune responses that predict protection. This vaccine development programme combines Oxford’s leadership in immunology and human challenge models with cutting-edge AI, laying the groundwork for a new era of vaccine discovery – one that is faster, smarter, and better able to respond to infectious disease outbreaks throughout the world.”
Professor Irene Tracey, Vice-Chancellor of the University of Oxford, said: “This is a major step forward in our strategic alliance with the Ellison Institute. Together, we’re combining Oxford’s strengths in vaccine science with EIT’s bold vision to tackle some of the toughest problems in global health. This is about drawing more talent and capacity to the Oxford ecosystem to turn scientific challenges into real solutions for the world.”
AI Research
National AI congress in natural resources to spotlight challenges in education, research

TEHRAN – The first national congress on artificial intelligence (AI) in natural resources aims to focus on challenges in education, research, and its applications in agriculture, natural resources, and the environment.
The two-day event will be held from September 4–5 at Shiraz University, Fars Province, with the theme ‘intelligent technology, green land, and sustainable future.
It highlights the integration of emerging technologies, such as AI, in research and technological projects.
Over 30 lecturers will share their scientific and research achievements through presentations divided into six panels and two specialized meetings, ISNA reported.
Two specialized sessions titled ‘Artificial Intelligence: Governance in Education and Research’ and ‘Precision Agriculture: Adoption, Education, Infrastructure’ will focus on AI challenges in education, research, and its application in agriculture.
The congress will be centered around productivity and promotion of natural and agricultural industries, smart management of water resources and climate, meteorology, climate change and ecosystem, sustainable agriculture, smart agriculture, big data and agricultural development, biodiversity and pests, remote sensing of natural resources, nature management, improvement of food quality and security, smart robotics, technological education, as well as ethical research in agriculture.
Some $100 million allocated to develop AI
In April, the Vice Presidency for Science, Technology, and Knowledge-Based Economy and the National Development Fund (NDF) signed a memorandum of understanding (MOU) to create a 100-million-dollar fund for the development of the artificial intelligence (AI) sector in the country.
Signed by Hossein Afshin, an official with the vice-presidency of science and technology, and Mehdi Ghazanfari, the head of the NDF, the MOU aims to establish a framework for the development and implementation of AI in line with the seventh national development plan (2023-2027) and the Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei’s emphasis on investing in emerging fields, ISNA reported.
Accordingly, the projects introduced by the vice-presidency for science and technology will be funded through loans, partnerships, and other ways of financing. To further boost cooperation between universities and the private sector, the NDF will grant specific loans to those companies that financially support AI-based projects in universities and scientific centers.
In return, the vice-presidency for science and technology will use financing tools for emerging technologies.
MT/MG
-
Business3 days ago
The Guardian view on Trump and the Fed: independence is no substitute for accountability | Editorial
-
Tools & Platforms3 weeks ago
Building Trust in Military AI Starts with Opening the Black Box – War on the Rocks
-
Ethics & Policy1 month ago
SDAIA Supports Saudi Arabia’s Leadership in Shaping Global AI Ethics, Policy, and Research – وكالة الأنباء السعودية
-
Events & Conferences3 months ago
Journey to 1000 models: Scaling Instagram’s recommendation system
-
Jobs & Careers2 months ago
Mumbai-based Perplexity Alternative Has 60k+ Users Without Funding
-
Funding & Business2 months ago
Kayak and Expedia race to build AI travel agents that turn social posts into itineraries
-
Education2 months ago
VEX Robotics launches AI-powered classroom robotics system
-
Podcasts & Talks2 months ago
Happy 4th of July! 🎆 Made with Veo 3 in Gemini
-
Mergers & Acquisitions2 months ago
Donald Trump suggests US government review subsidies to Elon Musk’s companies
-
Podcasts & Talks2 months ago
OpenAI 🤝 @teamganassi